SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY FLASH L impact

CytomX to Receive $5 Million Milestone Payment From Regeneron Collaboration

CytomX Therapeutics achieved a preclinical milestone in its collaboration with Regeneron, triggering a $5 million payment.

REGNCTMX

Related stories